Search Results for type:"Notice"

The Department of Commerce has determined that producers and exporters from China are receiving countervailable subsidies for corrosion inhibitors, meaning the subsidies unfairly aid these companies and could harm U.S. competition. This final decision is part of an investigation that goes back to January 1, 2019, and covers substances like tolyltriazole and benzotriazole. The investigation will proceed into whether these imports injure or threaten U.S. industries, with potential consequences including duties on imports. The findings are available in public documents for further review.

The Securities and Exchange Commission has published a notice about a proposed rule change by The Depository Trust Company (DTC). This proposal seeks to amend the Clearing Agency Investment Policy to ensure compliance with new requirements for handling and investing customer funds. Key changes include separating and independently managing the margin for proprietary transactions from those involving indirect participants, as well as restrictions on how these funds can be invested, primarily in U.S. Treasuries with short maturities. The proposal aims to align with regulations that safeguard the funds that DTC manages.

The Food and Drug Administration (FDA) announced a new date for the previously canceled public meeting on "Patient-Focused Drug Development for Vitiligo," now scheduled for March 8, 2021, in a virtual format. This meeting aims to gather patient input on how vitiligo affects their daily lives, their views on current treatment options, and how they decide on treatments. Participants can submit comments electronically or by mail until May 10, 2021, using the docket number FDA-2020-N-0255. The FDA seeks to understand patient perspectives to improve understanding and treatment approaches for vitiligo.

The Food and Drug Administration (FDA) is considering using the Clinical Data Interchange Standards Consortium (CDISC) Dataset—JavaScript Object Notation (Dataset-JSON) version 1.1 as a new format to submit electronic study data, which may replace the current SAS version 5 XPORT Transport Format. They are asking for comments from the industry about this potential change, specifically about the advantages and disadvantages and any difficulties that might emerge when integrating it with current systems. The FDA conducted a pilot study and is open to more tests to ensure a smooth transition. Public comments on this matter are due by June 9, 2025.

The Peabody Museum of Archaeology and Ethnology at Harvard University plans to return cultural items to the Northern Arapaho Tribe from the Wind River Reservation, Wyoming, as outlined under the Native American Graves Protection and Repatriation Act (NAGPRA). These items include a medicine rattle and a headdress that originally belonged to Chief Yellow Calf and were acquired in 1931 before being donated to the museum in 1957. The repatriation can occur after May 30, 2025, and the museum will consider additional requests from Southern organizations with proven cultural ties to the items. The determination process is solely the museum's responsibility, and the National Park Service facilitates this announcement without being liable for these decisions.

Columbia Gas Transmission, LLC has requested approval from the Federal Energy Regulatory Commission (FERC) to abandon two wells and associated facilities in West Virginia due to safety reasons. The project, which is estimated to cost $1.4 million, aims to reduce risk in line with federal safety guidelines. The public can participate by filing a protest, moving to intervene, or commenting on the project, with submissions due by April 8, 2025. Additional information and assistance are available through FERC's website and support services.

The United States Postal Service has filed a request with the Postal Regulatory Commission to add a new domestic shipping contract to its list of Negotiated Service Agreements. This involves the inclusion of Priority Mail Express, Priority Mail, and USPS Ground Advantage in their Competitive Products List. The request was officially filed on December 16, 2024, and detailed documents are accessible via the Commission’s website. For additional information, Sean C. Robinson can be contacted at the provided phone number.

The National Institute of Allergy and Infectious Diseases is holding two closed meetings to review and evaluate contract proposals. These meetings will focus on reagents for immunologic analysis of non-mammalian and underrepresented mammalian models as part of the Small Business Innovation Research (SBIR) program. The first meeting for Phase I will occur on January 28, 2021, from 10:00 a.m. to 6:00 p.m., and the second meeting for Phase II will take place on January 29, 2021, from 10:00 a.m. to 2:00 p.m. Both meetings will be held virtually and closed to the public to protect confidential trade secrets and personal privacy.

The Office on Violence Against Women within the Department of Justice is proposing to extend an existing information collection. They are seeking feedback on the necessity and effectiveness of this information collection, which involves applicants for grants related to the Violence Against Women Act. The information will be used to evaluate and improve grant programs designed to combat domestic violence, dating violence, sexual assault, and stalking. Public comments will be accepted until January 31, 2025.

The Centers for Disease Control and Prevention (CDC) announced a closed meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel, scheduled for March 11, 2025. The meeting, which will be held via teleconference, will focus on reviewing and evaluating grant applications. It is closed to the public because discussions might reveal trade secrets, commercial property, or private information about individuals involved in the grant applications. For more details, interested parties are encouraged to contact Catherine Barrett, the Scientific Review Officer at the CDC.